Two-Year Outcomes in High Bleeding Risk Patients With Bifurcations After Percutaneous Coronary Intervention and One Month of Dual Antiplatelet Therapy

被引:0
|
作者
Kirtane, Ajay [1 ]
Kandzari, David [2 ]
Latib, Azeem [3 ]
Kedhi, Elvin [4 ]
Mehran, Roxana [5 ]
Price, Matthew [6 ]
Simon, Daniel [7 ]
Abizaid, Alexandre [8 ]
Parke, Maria [9 ]
Lung, Te-Hsin [10 ]
Windecker, Stephan [11 ]
Stone, Gregg [5 ]
机构
[1] Columbia Univ, NewYork Presbyterian, Irving Med Ctr, New York, NY USA
[2] Piedmont Heart Inst, Atlanta, GA USA
[3] Montefiore Med Ctr, Scarsdale, NY USA
[4] Univ Libre Bruxelles, Erasme Hosp, Brussels, Netherlands
[5] Mt Sinai Heart Hlth Syst, New York, NY USA
[6] Scripps Clin, La Jolla, CA 92037 USA
[7] Univ Hosp Case Med Ctr, Cleveland, OH USA
[8] Univ Sao Paulo, Inst Coracao, Sao Paulo, Brazil
[9] Medtronic, Forest Lake, MN USA
[10] Medtronic, San Jose, CA USA
[11] Cardiovasc Ctr Bern, Bern, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-2
引用
收藏
页码:B1 / B1
页数:1
相关论文
共 50 条
  • [1] Clinical Outcomes in Patients With High Bleeding Risk and Bifurcations After Percutaneous Coronary Intervention With Resolute Onyx and 1-Month Dual Antiplatelet Therapy
    Kirtane, Ajay
    Kandzari, David
    Latib, Azeem
    Kedhi, Elvin
    Mehran, Roxana
    Price, Matthew
    Simon, Daniel
    Abizaid, Alexandre
    Parke, Maria
    Lung, Te-Hsin
    Windecker, Stephan
    Stone, Gregg
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B41 - B42
  • [2] One-Month Dual Antiplatelet Therapy in High Bleeding Risk Asian Patients Undergoing Percutaneous Coronary Intervention - Onyx ONE Clear 2-Year Results -
    Kang, Jeehoon
    Ghapar, Abdul Kahar Abdul
    Selvaraj, Kamaraj
    Hur, Seung-Ho
    Tam, Chor Cheung
    Jang, Yangsoo
    Chae, In-Ho
    Kandzari, David E.
    Kirtane, Ajay J.
    Latib, Azeem
    Kedhi, Elvin
    Lung, Te-Hsin
    You, So-Jeong
    Windecker, Stephan
    Stone, Gregg W.
    Kim, Hyo-Soo
    CIRCULATION REPORTS, 2024, 6 (08) : 333 - 340
  • [3] One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
    Kandzari, David E.
    Kirtane, Ajay J.
    Windecker, Stephan
    Latib, Azeem
    Kedhi, Elvin
    Mehran, Roxana
    Price, Matthew J.
    Abizaid, Alexandre
    Simon, Daniel I.
    Worthley, Stephen G.
    Zaman, Azfar
    Choi, James W.
    Caputo, Ronald
    Kanitkar, Mihir
    McLaurin, Brent
    Potluri, Srinivasa
    Smith, Timothy
    Spriggs, Douglas
    Tolleson, Thaddeus
    Nazif, Tamim
    Parke, Maria
    Lee, Lilian C.
    Lung, Te-Hsin
    Stone, Gregg W.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (11) : E009565
  • [4] Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and meta-analysis
    Han, Yan
    Yuan, Xiaohang
    Hu, Xin
    Fang, Yan
    Jiang, Mengting
    Feng, Huanhuan
    Gao, Lei
    CARDIOLOGY JOURNAL, 2023, 30 (04) : 556 - 566
  • [5] Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk
    Nakamura, Masato
    Kadota, Kazushige
    Nakao, Koichi
    Nakagawa, Yoshihisa
    Shite, Junya
    Yokoi, Hiroyoshi
    Kozuma, Ken
    Tanabe, Kengo
    Akasaka, Takashi
    Shinke, Toshiro
    Ueno, Takafumi
    Hirayama, Atsushi
    Uemura, Shiro
    Harada, Atsushi
    Kuroda, Takeshi
    Takita, Atsushi
    Iijima, Raisuke
    Murakami, Yoshitaka
    Saito, Shigeru
    CIRCULATION JOURNAL, 2021, 85 (06) : 785 - +
  • [6] What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?
    Zhao, Yuqin
    Chen, Yafang
    EUROPEAN HEART JOURNAL, 2024, 45 (01) : 70 - 70
  • [7] Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
    Pelliccia, Francesco
    Gragnano, Felice
    Pasceri, Vincenzo
    Cesaro, Arturo
    Zimarino, Marco
    Calabro, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [8] Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk
    Mauro, Maria Sara
    Capodanno, Davide
    THROMBOSIS AND HAEMOSTASIS, 2025,
  • [9] Does Age Have a Differential Effect on 1 Month Versus 3 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk?
    Elkaryoni, Ahmed
    Garg, Aakash
    Abbott, J. Dawn
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 215 : 96 - 97
  • [10] Meta-Analysis of Bleeding Risk Prediction Scores in Patients After Percutaneous Coronary Intervention on Dual Antiplatelet Therapy
    Ko, Stephanie Q.
    Valsdottir, Linda R.
    Strom, Jordan B.
    Cheng, Yu-Chen
    Hirayama, Atsushi
    Liu, Po-Hong
    Yanagisawa, Naoki
    Yen, Hsuan
    Shen, Changyu
    Yeh, Robert W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (11): : 1843 - 1852